Dexmedetomidine Transdermal System (DMTS)

dexmedetomidine · Teikoku Pharma USA, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dexmedetomidine Transdermal System (DMTS), covering 2017-10-09 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type [Phase 2]

See pricing